Featured Research

from universities, journals, and other organizations

Kidney With Tumor Removed Through Vagina

Date:
March 21, 2009
Source:
Instituto Medico La Floresta
Summary:
A kidney with a tumor was removed through the patient's vagina. The operation lasted 220 minutes followed by a two day hospital stay. The patient experienced no complications and was discharged from the hospital with no visible abdominal scar.

Dr. Rene Sotelo has announced what he believes to be the world's first successful live human transvaginal nephrectomy using the Tri-port multi-channel port supplied by Advanced Surgical Concepts Ltd. This ground breaking surgery was performed by Dr. Sotelo and his team at the Instituto Medico La Floresta in Caracas, Venezuela on March 7, 2009.

The majority of the intra-operative endoscopic visualization and tissue mobilization for the natural orifice transluminal endoscopic surgery (NOTES) nephrectomy was performed transvaginally, with observation and occasional assistance from an intra-umbilical Tri-port. No extra-umbilical incisions were needed.

The patient was a 65 year-old female with a 6 cm left kidney tumor and a prior history of hysterectomy. The operation lasted 220 minutes followed by a two day hospital stay. The patient experienced no complications and was discharged from the hospital with no visible abdominal scar. At this writing, March 13, six days post-operative, the patient continues to do well in excellent recovery.

Dr. Sotelo remarks, "This concept of using the Tri-port for transvaginal NOTES nephrectomy was first described in a cadaveric study presented at the World Congress of Endurourology in 2008 by Drs. Monish Aron, Mihir Desai, and Inderbir Gill. I sought their advice and collaboration in our operation. The procedure went well and has great potential for the future."


Story Source:

The above story is based on materials provided by Instituto Medico La Floresta. Note: Materials may be edited for content and length.


Cite This Page:

Instituto Medico La Floresta. "Kidney With Tumor Removed Through Vagina." ScienceDaily. ScienceDaily, 21 March 2009. <www.sciencedaily.com/releases/2009/03/090313171320.htm>.
Instituto Medico La Floresta. (2009, March 21). Kidney With Tumor Removed Through Vagina. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/03/090313171320.htm
Instituto Medico La Floresta. "Kidney With Tumor Removed Through Vagina." ScienceDaily. www.sciencedaily.com/releases/2009/03/090313171320.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins